v3.25.4
Accrued Liabilities Detail - Schedule of Accrued Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Accrued Liabilities, Current [Abstract]    
Accrued compensation $ 6,948 $ 13,305
Cystic Fibrosis Foundation liability 6,394 7,443
Current portion of operating lease liability $ 4,214 $ 3,552
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total Total
Accrued facilities costs $ 1,400  
Clinical trial accruals 399 $ 2,828
Vinbiocare contractual liabilities   2,421
Legal accrual 771 130
Other accrued research and development expenses 3,772 9,102
Total $ 23,898 $ 38,781